Analgesics (Pharmacies) - Brunei Darussalam

  • Brunei Darussalam
  • Revenue in the Analgesics market is projected to reach US$1.08m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 6.70%, resulting in a market volume of US$1.40m by 2028.
  • In global comparison, most revenue will be generated in China (US$5,028.00m in 2024).
  • In relation to total population figures, per person revenues of US$2.38 are generated in 2024.

Key regions: Europe, United States, Canada, India, South Korea

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics (Pharmacies) market in Brunei Darussalam is experiencing steady growth and development.

Customer preferences:
Customers in Brunei Darussalam have shown a growing preference for analgesics purchased from pharmacies. This preference can be attributed to the convenience and accessibility of pharmacies, as well as the trust that customers place in these establishments. Pharmacies in Brunei Darussalam are known for their knowledgeable staff and ability to provide personalized advice and recommendations to customers. Additionally, customers in Brunei Darussalam value the wide range of analgesic products available in pharmacies, allowing them to choose the most suitable option for their needs.

Trends in the market:
One of the key trends in the Analgesics (Pharmacies) market in Brunei Darussalam is the increasing demand for over-the-counter (OTC) analgesics. This trend can be attributed to the growing awareness among consumers about self-medication and the availability of OTC analgesics in pharmacies. Customers are increasingly seeking quick relief from common ailments such as headaches and muscle pain, and OTC analgesics provide a convenient and affordable solution. This trend is expected to continue driving the growth of the Analgesics (Pharmacies) market in Brunei Darussalam. Another trend in the market is the rising demand for natural and herbal analgesics. Customers in Brunei Darussalam are becoming more health-conscious and are seeking alternatives to conventional analgesics that may have potential side effects. Natural and herbal analgesics are perceived as safer and more gentle on the body, and customers are willing to pay a premium for these products. Pharmacies in Brunei Darussalam are responding to this trend by expanding their range of natural and herbal analgesics to cater to customer preferences.

Local special circumstances:
Brunei Darussalam has a relatively small population compared to other countries in the region. This presents both opportunities and challenges for the Analgesics (Pharmacies) market. On one hand, the small population size allows for easier market penetration and targeted marketing strategies. Pharmacies can focus on understanding the specific needs and preferences of the local population and tailor their product offerings accordingly. On the other hand, the small population size also means that the market may be limited in terms of growth potential. Pharmacies in Brunei Darussalam need to carefully manage their inventory and ensure that they are able to meet the demand of the local population without excessive wastage.

Underlying macroeconomic factors:
The stable and growing economy of Brunei Darussalam is a key factor driving the development of the Analgesics (Pharmacies) market. The country has a high per capita income, which enables consumers to afford healthcare products, including analgesics. Additionally, the government of Brunei Darussalam has been investing in the healthcare sector, which has led to improved healthcare infrastructure and services. This, in turn, has increased the accessibility and availability of analgesics in pharmacies. The government's focus on promoting healthcare and wellness also contributes to the growth of the Analgesics (Pharmacies) market in Brunei Darussalam.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)